PA
BSX icon

Paragon Advisors’s Boston Scientific BSX Stock Holding History

Paragon Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-43,490
Closed -$1.53M – 86
2020
Q2 		$1.53M Sell
43,490
-5,759
-12% -$207K 1.23% 14
2020
Q1 		$1.61M Buy
49,249
+2,833
+6% +$111K 2.14% 12
2019
Q4 		$2.12M Buy
+46,416
New +$1.94M 2.29% 11

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paragon Advisors's BSX Position: Q3 2020 in Review

Paragon Advisors sold out of Boston Scientific (BSX) in Q3 2020, closing a stake of 43,490 shares — an estimated $1.53M sold.

Paragon Advisors first reported a position in BSX in Q4 2019 and held it in 3 quarters. The position peaked at $2.12M in Q4 2019. 844 funds tracked by Wall St. Rank hold BSX as of Q3 2020.

  • Paragon Advisors reported no remaining Boston Scientific position as of Q3 2020 after selling out during the quarter.
  • Paragon Advisors sold 43,490 Boston Scientific shares in Q3 2020, an estimated $1.53M.
  • Paragon Advisors first reported a position in Boston Scientific in Q4 2019 and held it in 3 quarters.
  • Paragon Advisors's Boston Scientific position peaked at $2.12M in Q4 2019.
  • 844 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2020.

Based on Paragon Advisors's 13F filing for Q3 2020, filed 30 Oct 2020.